SK16952000A3 - Laminát na priloženie na akceptor - Google Patents

Laminát na priloženie na akceptor Download PDF

Info

Publication number: SK16952000A3
Authority: SK; Slovakia
Prior art keywords: layer; laminate according; film; laminate; layers
Prior art date: 1998-05-11

Application number

SK1695-2000A

Other languages

English (en)

Slovak (sk)

Inventor

Falkenhausen Christian Von

Original Assignee

Lts Lohmann Therapie-Systeme Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-11

Filing date

1999-04-29

Publication date

2001-07-10

1999-04-29 Application filed by Lts Lohmann Therapie-Systeme Ag filed Critical Lts Lohmann Therapie-Systeme Ag

2001-07-10 Publication of SK16952000A3 publication Critical patent/SK16952000A3/sk

Links

239000010410 layer Substances 0.000 claims abstract description 144
239000011241 protective layer Substances 0.000 claims abstract description 7
239000013543 active substance Substances 0.000 claims description 39
239000000853 adhesive Substances 0.000 claims description 13
230000001070 adhesive effect Effects 0.000 claims description 12
230000001225 therapeutic effect Effects 0.000 claims description 10
239000012790 adhesive layer Substances 0.000 claims description 6
239000011888 foil Substances 0.000 claims description 6
238000004519 manufacturing process Methods 0.000 claims description 6
230000001681 protective effect Effects 0.000 claims description 6
230000037303 wrinkles Effects 0.000 claims description 3
239000011248 coating agent Substances 0.000 claims description 2
238000000576 coating method Methods 0.000 claims description 2
230000004888 barrier function Effects 0.000 claims 1
230000000087 stabilizing effect Effects 0.000 claims 1
210000003491 skin Anatomy 0.000 description 46
239000000370 acceptor Substances 0.000 description 9
239000004480 active ingredient Substances 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
230000008901 benefit Effects 0.000 description 6
230000008602 contraction Effects 0.000 description 6
239000000463 material Substances 0.000 description 6
230000011218 segmentation Effects 0.000 description 6
238000000034 method Methods 0.000 description 5
230000001276 controlling effect Effects 0.000 description 4
238000012377 drug delivery Methods 0.000 description 4
150000003180 prostaglandins Chemical class 0.000 description 4
239000000126 substance Substances 0.000 description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
230000000694 effects Effects 0.000 description 3
230000006870 function Effects 0.000 description 3
230000035699 permeability Effects 0.000 description 3
-1 sympathimine Chemical compound 0.000 description 3
CNIIGCLFLJGOGP-UHFFFAOYSA-N 2-(1-naphthalenylmethyl)-4,5-dihydro-1H-imidazole Chemical compound C=1C=CC2=CC=CC=C2C=1CC1=NCCN1 CNIIGCLFLJGOGP-UHFFFAOYSA-N 0.000 description 2
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 2
239000004372 Polyvinyl alcohol Substances 0.000 description 2
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
239000000470 constituent Substances 0.000 description 2
GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
235000014113 dietary fatty acids Nutrition 0.000 description 2
239000013013 elastic material Substances 0.000 description 2
150000002148 esters Chemical class 0.000 description 2
229930195729 fatty acid Natural products 0.000 description 2
239000000194 fatty acid Substances 0.000 description 2
150000004665 fatty acids Chemical class 0.000 description 2
LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 2
CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
210000003127 knee Anatomy 0.000 description 2
XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
230000010412 perfusion Effects 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
229920002451 polyvinyl alcohol Polymers 0.000 description 2
230000009993 protective function Effects 0.000 description 2
229920006395 saturated elastomer Polymers 0.000 description 2
NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
DBGIVFWFUFKIQN-UHFFFAOYSA-N (+-)-Fenfluramine Chemical compound CCNC(C)CC1=CC=CC(C(F)(F)F)=C1 DBGIVFWFUFKIQN-UHFFFAOYSA-N 0.000 description 1
SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
IGLYMJRIWWIQQE-QUOODJBBSA-N (1S,2R)-2-phenylcyclopropan-1-amine (1R,2S)-2-phenylcyclopropan-1-amine Chemical compound N[C@H]1C[C@@H]1C1=CC=CC=C1.N[C@@H]1C[C@H]1C1=CC=CC=C1 IGLYMJRIWWIQQE-QUOODJBBSA-N 0.000 description 1
TWBNMYSKRDRHAT-RCWTXCDDSA-N (S)-timolol hemihydrate Chemical compound O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 TWBNMYSKRDRHAT-RCWTXCDDSA-N 0.000 description 1
WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
IVQOFBKHQCTVQV-UHFFFAOYSA-N 2-hydroxy-2,2-diphenylacetic acid 2-(diethylamino)ethyl ester Chemical compound C=1C=CC=CC=1C(O)(C(=O)OCCN(CC)CC)C1=CC=CC=C1 IVQOFBKHQCTVQV-UHFFFAOYSA-N 0.000 description 1
229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
229930003347 Atropine Natural products 0.000 description 1
239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
229940123907 Disease modifying antirheumatic drug Drugs 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
244000043261 Hevea brasiliensis Species 0.000 description 1
239000013032 Hydrocarbon resin Substances 0.000 description 1
RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
102000010909 Monoamine Oxidase Human genes 0.000 description 1
108010062431 Monoamine oxidase Proteins 0.000 description 1
STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
239000000006 Nitroglycerin Substances 0.000 description 1
PIJVFDBKTWXHHD-UHFFFAOYSA-N Physostigmine Natural products C12=CC(OC(=O)NC)=CC=C2N(C)C2C1(C)CCN2C PIJVFDBKTWXHHD-UHFFFAOYSA-N 0.000 description 1
229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
229920002367 Polyisobutene Polymers 0.000 description 1
208000025747 Rheumatic disease Diseases 0.000 description 1
229920002125 Sokalan® Polymers 0.000 description 1
239000002174 Styrene-butadiene Substances 0.000 description 1
GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
239000003098 androgen Substances 0.000 description 1
229940030486 androgens Drugs 0.000 description 1
230000003356 anti-rheumatic effect Effects 0.000 description 1
229940125715 antihistaminic agent Drugs 0.000 description 1
239000000739 antihistaminic agent Substances 0.000 description 1
239000003435 antirheumatic agent Substances 0.000 description 1
239000002249 anxiolytic agent Substances 0.000 description 1
230000000949 anxiolytic effect Effects 0.000 description 1
229940005530 anxiolytics Drugs 0.000 description 1
RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
229960000396 atropine Drugs 0.000 description 1
229960001498 benactyzine Drugs 0.000 description 1
238000005452 bending Methods 0.000 description 1
150000001591 beta-pinene derivatives Chemical class 0.000 description 1
229920001400 block copolymer Polymers 0.000 description 1
229960000330 bupranolol Drugs 0.000 description 1
HQIRNZOQPUAHHV-UHFFFAOYSA-N bupranolol Chemical compound CC1=CC=C(Cl)C(OCC(O)CNC(C)(C)C)=C1 HQIRNZOQPUAHHV-UHFFFAOYSA-N 0.000 description 1
MTAZNLWOLGHBHU-UHFFFAOYSA-N butadiene-styrene rubber Chemical compound C=CC=C.C=CC1=CC=CC=C1 MTAZNLWOLGHBHU-UHFFFAOYSA-N 0.000 description 1
229960003609 cathine Drugs 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
229960001076 chlorpromazine Drugs 0.000 description 1
230000001713 cholinergic effect Effects 0.000 description 1
229960005233 cineole Drugs 0.000 description 1
229960002881 clemastine Drugs 0.000 description 1
YNNUSGIPVFPVBX-NHCUHLMSSA-N clemastine Chemical compound CN1CCC[C@@H]1CCO[C@@](C)(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 YNNUSGIPVFPVBX-NHCUHLMSSA-N 0.000 description 1
230000009194 climbing Effects 0.000 description 1
229960002896 clonidine Drugs 0.000 description 1
239000000824 cytostatic agent Substances 0.000 description 1
230000001085 cytostatic effect Effects 0.000 description 1
229960003529 diazepam Drugs 0.000 description 1
AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
HESHRHUZIWVEAJ-JGRZULCMSA-N dihydroergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2[C@@H](C3=CC=CC4=NC=C([C]34)C2)C1)C)C1=CC=CC=C1 HESHRHUZIWVEAJ-JGRZULCMSA-N 0.000 description 1
229960004704 dihydroergotamine Drugs 0.000 description 1
125000004925 dihydropyridyl group Chemical group N1(CC=CC=C1)* 0.000 description 1
229960000520 diphenhydramine Drugs 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
239000000262 estrogen Substances 0.000 description 1
229940011871 estrogen Drugs 0.000 description 1
229960001582 fenfluramine Drugs 0.000 description 1
239000012530 fluid Substances 0.000 description 1
238000009472 formulation Methods 0.000 description 1
229960003711 glyceryl trinitrate Drugs 0.000 description 1
229960003878 haloperidol Drugs 0.000 description 1
229920006270 hydrocarbon resin Polymers 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
229960000905 indomethacin Drugs 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
238000009413 insulation Methods 0.000 description 1
235000001510 limonene Nutrition 0.000 description 1
229940087305 limonene Drugs 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000003589 local anesthetic agent Substances 0.000 description 1
229960005015 local anesthetics Drugs 0.000 description 1
OXROWJKCGCOJDO-JLHYYAGUSA-N lornoxicam Chemical compound O=C1C=2SC(Cl)=CC=2S(=O)(=O)N(C)\C1=C(\O)NC1=CC=CC=N1 OXROWJKCGCOJDO-JLHYYAGUSA-N 0.000 description 1
229960002202 lornoxicam Drugs 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
229940041616 menthol Drugs 0.000 description 1
239000000203 mixture Substances 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
229960005016 naphazoline Drugs 0.000 description 1
229920003052 natural elastomer Polymers 0.000 description 1
229920001194 natural rubber Polymers 0.000 description 1
229960002715 nicotine Drugs 0.000 description 1
SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
229960001597 nifedipine Drugs 0.000 description 1
XNGIFLGASWRNHJ-UHFFFAOYSA-N o-dicarboxybenzene Natural products OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 1
229940005483 opioid analgesics Drugs 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
229940127557 pharmaceutical product Drugs 0.000 description 1
150000002990 phenothiazines Chemical class 0.000 description 1
PIJVFDBKTWXHHD-HIFRSBDPSA-N physostigmine Chemical compound C12=CC(OC(=O)NC)=CC=C2N(C)[C@@H]2[C@@]1(C)CCN2C PIJVFDBKTWXHHD-HIFRSBDPSA-N 0.000 description 1
229960001697 physostigmine Drugs 0.000 description 1
229960002702 piroxicam Drugs 0.000 description 1
QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
239000004014 plasticizer Substances 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
229920000193 polymethacrylate Polymers 0.000 description 1
229920000098 polyolefin Polymers 0.000 description 1
229920002635 polyurethane Polymers 0.000 description 1
239000004814 polyurethane Substances 0.000 description 1
229920000915 polyvinyl chloride Polymers 0.000 description 1
239000004800 polyvinyl chloride Substances 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
239000000583 progesterone congener Substances 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
229920005989 resin Polymers 0.000 description 1
239000011347 resin Substances 0.000 description 1
230000000552 rheumatic effect Effects 0.000 description 1
229960002052 salbutamol Drugs 0.000 description 1
STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
229960002646 scopolamine Drugs 0.000 description 1
MEZLKOACVSPNER-GFCCVEGCSA-N selegiline Chemical compound C#CCN(C)[C@H](C)CC1=CC=CC=C1 MEZLKOACVSPNER-GFCCVEGCSA-N 0.000 description 1
229960003946 selegiline Drugs 0.000 description 1
229920005573 silicon-containing polymer Polymers 0.000 description 1
210000002460 smooth muscle Anatomy 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000007858 starting material Substances 0.000 description 1
210000000434 stratum corneum Anatomy 0.000 description 1
210000003699 striated muscle Anatomy 0.000 description 1
239000011115 styrene butadiene Substances 0.000 description 1
229920003048 styrene butadiene rubber Polymers 0.000 description 1
239000000758 substrate Substances 0.000 description 1
230000003319 supportive effect Effects 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
229960000351 terfenadine Drugs 0.000 description 1
150000003505 terpenes Chemical class 0.000 description 1
235000007586 terpenes Nutrition 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
229960004605 timolol Drugs 0.000 description 1
229960003741 tranylcypromine Drugs 0.000 description 1
150000003626 triacylglycerols Chemical class 0.000 description 1
JOFWLTCLBGQGBO-UHFFFAOYSA-N triazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1Cl JOFWLTCLBGQGBO-UHFFFAOYSA-N 0.000 description 1
229960003386 triazolam Drugs 0.000 description 1
210000000689 upper leg Anatomy 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B7/00—Layered products characterised by the relation between layers; Layered products characterised by the relative orientation of features between layers, or by the relative values of a measurable parameter between layers, i.e. products comprising layers having different physical, chemical or physicochemical properties; Layered products characterised by the interconnection of layers
- B32B7/04—Interconnection of layers
- B32B7/06—Interconnection of layers permitting easy separation

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Dermatology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Birds (AREA)
Biomedical Technology (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)
Laminated Bodies (AREA)
Electroplating Methods And Accessories (AREA)

SK1695-2000A 1998-05-11 1999-04-29 Laminát na priloženie na akceptor SK16952000A3 (sk)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19820999A DE19820999A1 (de)	1998-05-11	1998-05-11	Laminat zum Aufbringen auf einen Akzeptor
PCT/EP1999/002897 WO1999058089A1 (de)	1998-05-11	1999-04-29	Laminat zum aufbringen auf einen akzeptor

Publications (1)

Publication Number	Publication Date
SK16952000A3 true SK16952000A3 (sk)	2001-07-10

Family

ID=7867359

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK1695-2000A SK16952000A3 (sk)	1998-05-11	1999-04-29	Laminát na priloženie na akceptor

Country Status (16)

Country	Link
EP (1)	EP1077663A1 (id)
JP (1)	JP2002514523A (id)
KR (1)	KR20010071242A (id)
AU (1)	AU4035499A (id)
CA (1)	CA2332012A1 (id)
DE (1)	DE19820999A1 (id)
HU (1)	HUP0101825A2 (id)
ID (1)	ID26661A (id)
IL (1)	IL139510A0 (id)
NO (1)	NO20005731L (id)
PL (1)	PL344253A1 (id)
SK (1)	SK16952000A3 (id)
TR (1)	TR200003320T2 (id)
TW (1)	TW431897B (id)
WO (1)	WO1999058089A1 (id)
ZA (1)	ZA200006492B (id)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10056014A1 (de) *	2000-11-11	2002-05-16	Beiersdorf Ag	Mehrschichtige Trägerkonstruktion für wirkstofhaltige Pflastersyteme
DE102010020050A1 (de) *	2010-05-11	2011-11-17	Ivf Hartmann Ag	Wundauflage
KR101160976B1 (ko) *	2010-07-19	2012-06-29	주식회사 글루칸	치주질환의 치료 또는 예방용 조성물
US10966936B2 (en) *	2015-12-30	2021-04-06	Corium, Inc.	Systems comprising a composite backing and methods for long term transdermal administration
WO2017223402A1 (en)	2016-06-23	2017-12-28	Corium International, Inc.	Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
CN116270551A (zh)	2016-07-27	2023-06-23	考里安有限责任公司	通过盐至中性药物原位转化的组合物、透皮贴剂及应用
US11173132B2 (en)	2017-12-20	2021-11-16	Corium, Inc.	Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
ES2878332T3 (es) *	2019-02-26	2021-11-18	Moelnlycke Health Care Ab	Proceso para introducir perforaciones en laminados que comprenden geles de silicona

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2340205A1 (de) *	1973-08-08	1975-02-20	Btr Industries Ltd	Wundverband
DE3634016A1 (de) *	1986-04-17	1987-10-29	Lohmann Gmbh & Co Kg	Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
DE8623009U1 (de) *	1986-08-28	1987-03-12	Lohmann Gmbh & Co Kg, 5450 Neuwied	Transdermales Pflaster
DE3714140A1 (de) *	1987-04-28	1988-11-10	Lohmann Therapie Syst Lts	Wirkstoffhaltiges pflaster zur kontrollierten verabreichung von wirkstoffen an die haut, seine verwendung sowie verfahren zur gesteuerten verabreichung von wirkstoffen an die haut
DE3809978A1 (de) *	1988-03-24	1989-10-05	Lohmann Gmbh & Co Kg	Reservoir fuer gesteuerte wirkstoffabgabe, dieses enthaltende vorrichtung, sowie verfahren zu deren herstellung und verwendung der vorrichtung
DE3810658A1 (de) *	1988-03-29	1989-10-12	Lohmann Gmbh & Co Kg	Pflaster, insbesondere epikutantestpflaster und verfahren zur herstellung desselben
NL9100548A (nl) *	1991-03-27	1992-10-16	Nijverdal Ten Cate Textiel	Pleister met een voorraad medisch werkzame substantie.
DK5492A (da) *	1992-01-17	1993-07-18	Coloplast As	Hudpladeprodukt
EP0643954A1 (en) *	1993-09-17	1995-03-22	Nobutaka Tanaka	Adhesive plaster
WO1997045079A1 (en) *	1996-05-24	1997-12-04	Coloplast A/S	A permanently deformable dressing

1998
- 1998-05-11 DE DE19820999A patent/DE19820999A1/de not_active Withdrawn
1999
- 1999-04-29 KR KR1020007012650A patent/KR20010071242A/ko not_active Withdrawn
- 1999-04-29 JP JP2000547941A patent/JP2002514523A/ja active Pending
- 1999-04-29 AU AU40354/99A patent/AU4035499A/en not_active Abandoned
- 1999-04-29 TR TR2000/03320T patent/TR200003320T2/xx unknown
- 1999-04-29 IL IL13951099A patent/IL139510A0/xx unknown
- 1999-04-29 EP EP99923493A patent/EP1077663A1/de not_active Withdrawn
- 1999-04-29 CA CA002332012A patent/CA2332012A1/en not_active Abandoned
- 1999-04-29 PL PL99344253A patent/PL344253A1/xx not_active Application Discontinuation
- 1999-04-29 SK SK1695-2000A patent/SK16952000A3/sk unknown
- 1999-04-29 WO PCT/EP1999/002897 patent/WO1999058089A1/de not_active Ceased
- 1999-04-29 ID IDW20002318A patent/ID26661A/id unknown
- 1999-04-29 HU HU0101825A patent/HUP0101825A2/hu unknown
- 1999-05-05 TW TW088107283A patent/TW431897B/zh active
2000
- 2000-11-09 ZA ZA200006492A patent/ZA200006492B/en unknown
- 2000-11-13 NO NO20005731A patent/NO20005731L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
HUP0101825A2 (hu)	2001-10-28
TW431897B (en)	2001-05-01
ID26661A (id)	2001-01-25
EP1077663A1 (de)	2001-02-28
NO20005731D0 (no)	2000-11-13
KR20010071242A (ko)	2001-07-28
PL344253A1 (en)	2001-10-22
CA2332012A1 (en)	1999-11-18
ZA200006492B (en)	2002-10-04
WO1999058089A1 (de)	1999-11-18
JP2002514523A (ja)	2002-05-21
IL139510A0 (en)	2001-11-25
TR200003320T2 (tr)	2001-02-21
AU4035499A (en)	1999-11-29
DE19820999A1 (de)	1999-11-18
NO20005731L (no)	2000-11-13

Publication	Publication Date	Title
US4769028A (en)	1988-09-06	Pharmaceutical product, in medical bandage form
EP2025310B1 (en)	2011-11-09	Patch and adhesive preparation
US5520762A (en)	1996-05-28	Method of manufucturing a wound dressing delivery system
US20090216169A1 (en)	2009-08-27	Layered product with adhesive dressing for non-touch application
JP4388068B2 (ja)	2009-12-24	活性剤移動バリア層を含む経皮パッチ
EP0117027A1 (en)	1984-08-29	Drug delivery device
US7955677B2 (en)	2011-06-07	Two-sided non-stick release film
CA2183083A1 (en)	1995-09-14	Drug-containing adhesive composite transdermal delivery device
JP2000514063A (ja)	2000-10-24	非閉塞性医薬伝達器具及びその製造方法
SK278995B6 (sk)	1998-05-06	Spôsob kontinuálnej výroby transdermálnej terapeut
WO2005025549A2 (en)	2005-03-24	Multi-layer transdermal drug delivery device
JP2008543768A (ja)	2008-12-04	接着性積層体区画を取り扱うための方法
EP0144486B1 (en)	1991-11-27	Controlled-release drugsystem and process for preparing it
SK16952000A3 (sk)	2001-07-10	Laminát na priloženie na akceptor
EP2316437B1 (en)	2014-07-30	Multilayer drug delivery system with barrier against reservoir material flow
CA2480683A1 (en)	2003-10-02	Assembled unit consisting of individually separable transdermal therapeutic systems
JP2010018539A (ja)	2010-01-28	外用貼付剤および外用貼付剤の貼付方法
HUP0003347A2 (hu)	2001-02-28	Transzdermális terápiás rendszer (TTS) hatóanyag leadásához és eljárás a bőrre történő alkalmazáshoz
US5972376A (en)	1999-10-26	Transdermal system of tacrine/selegilin-plaster
CZ20004196A3 (cs)	2001-05-16	Laminát pro přiložení na akceptor
US20050118245A1 (en)	2005-06-02	Assembled unit consisting of individually separable, transdermal, therapeutic systems
WO2005084255A2 (en)	2005-09-15	Aspirin transdermal patch
MXPA00011071A (en)	2002-05-09	Laminate for application onto an acceptor
KR0167583B1 (ko)	1999-01-15	경피투약을 위한 조성물 및 적층복합체
ES2352317T3 (es)	2011-02-17	Sistema de administración de medicamentos multicapas equipado de una protección contra el derramamiento de material de depósito.